Home

Visibile Paterno Summon lama laba ics Uva perturbazione Nazione

Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in  Real-World Clinical Practice - ScienceDirect
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect

effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download  Table
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table

Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of  Acute Exacerbation in Patients with Coexistent COPD and Asthma -  ScienceDirect
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d |  COPD
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in  COPD targeted by blood eosinophils: a population-based cohort study - The  Lancet Respiratory Medicine
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine

Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination  Therapy in COPD | Semantic Scholar
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar

De-escalation of ICS in COPD. Abbreviations: ICS, inhaled... | Download  Scientific Diagram
De-escalation of ICS in COPD. Abbreviations: ICS, inhaled... | Download Scientific Diagram

BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor  News, il Blog di Carlo Cottone
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone

Avances En Respiratorio | LAMA/LABA vs. LABA/ICS: la evidencia Cochrane |  Notícias
Avances En Respiratorio | LAMA/LABA vs. LABA/ICS: la evidencia Cochrane | Notícias

Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination  Therapy in COPD | Semantic Scholar
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar

INTERNISTI E BPCO
INTERNISTI E BPCO

Full article: A Pooled Analysis of Mortality in Patients with COPD  Receiving Dual Bronchodilation with and without Additional Inhaled  Corticosteroid
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid

Effectiveness and Safety of COPD Maintenance Therapy with  Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in  Therapy
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy

JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary  of the Evidence and Guideline Recommendations
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations

Comparing LAMA with LABA and LTRA as add-on therapies in primary care  asthma management | npj Primary Care Respiratory Medicine
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in  COPD targeted by blood eosinophils: a population-based cohort study - The  Lancet Respiratory Medicine
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine

A new alphabet for COPD care | European Respiratory Society
A new alphabet for COPD care | European Respiratory Society

Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... |  Download Scientific Diagram
Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram

Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial  inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some  https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6  https://t.co/uepZ7YPZsV" / X
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X

COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting

American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but  incidence of pneumonia increased with triple therapy initiation:  https://hubs.ly/H0pPLQ20 | Facebook
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook

Frontiers | Single Inhaler LABA/LAMA for COPD
Frontiers | Single Inhaler LABA/LAMA for COPD

Frontiers | Single Inhaler LABA/LAMA for COPD
Frontiers | Single Inhaler LABA/LAMA for COPD

Rational use of inhaled corticosteroids for the treatment of COPD | npj  Primary Care Respiratory Medicine
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine